International consensus statement on allergy and rhinology: Allergic rhinitis–2023
SK Wise, C Damask, LT Roland, C Ebert… - International forum of …, 2023 - Wiley Online Library
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
B David, M Bafadhel, L Koenderman, A De Soyza - Thorax, 2021 - thorax.bmj.com
The heterogeneity of chronic obstructive pulmonary disease (COPD) creates many
diagnostic, prognostic, treatment and management challenges, as the pathogenesis of …
diagnostic, prognostic, treatment and management challenges, as the pathogenesis of …
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label …
P Sivapalan, TS Lapperre, J Janner… - The Lancet …, 2019 - thelancet.com
Background Treatment with systemic corticosteroids in patients with acute exacerbations of
chronic obstructive pulmonary disease (COPD) is associated with debilitating adverse …
chronic obstructive pulmonary disease (COPD) is associated with debilitating adverse …
The prognostic value of blood eosinophil level in AECOPD is influenced by corticosteroid treatment during hospitalization
J Li, L Liang, L Feng, S Cao, YS Cai, X Li… - Journal of …, 2023 - Taylor & Francis
Purpose Blood eosinophil is a promising biomarker for phenotyping patients with acute
exacerbation of COPD (AECOPD). We aimed to evaluate the prognostic value of eosinophil …
exacerbation of COPD (AECOPD). We aimed to evaluate the prognostic value of eosinophil …
[HTML][HTML] Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease
CW Wu, CC Lan, PC Hsieh, IS Tzeng… - World journal of clinical …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Eosinophil counts are a promising guide to systemic steroid administration
for chronic obstructive pulmonary disease (COPD). AIM To study the role of peripheral …
for chronic obstructive pulmonary disease (COPD). AIM To study the role of peripheral …
Phase II study of single/repeated doses of acumapimod (BCT197) to treat acute exacerbations of COPD
IR Strâmbu, ZD Kobalava, BP Magnusson… - COPD: Journal of …, 2019 - Taylor & Francis
Mitogen-activated protein kinase p38 is a key regulator in the inflammation pathway and is
activated in the lungs of chronic obstructive pulmonary disease (COPD) patients …
activated in the lungs of chronic obstructive pulmonary disease (COPD) patients …
[HTML][HTML] Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
P Sivapalan, A Bikov, JU Jensen - Diagnostics, 2021 - mdpi.com
Treating patients hospitalised with acute exacerbations of chronic obstructive pulmonary
disease (COPD) usually involves administering systemic corticosteroids. The many …
disease (COPD) usually involves administering systemic corticosteroids. The many …
Management of chronic obstructive pulmonary disease
G Katzenberg, A Deacon, J Aigbirior… - British Journal of …, 2021 - magonlinelibrary.com
Chronic obstructive pulmonary disease is a prevalent condition in the UK, associated with
high morbidity and mortality. Hospital physicians manage a significant portion of acute …
high morbidity and mortality. Hospital physicians manage a significant portion of acute …
[HTML][HTML] Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD
J Zhu, P Mallia, J Footitt, Y Qiu, SD Message… - Journal of Allergy and …, 2020 - Elsevier
Background Respiratory viral infection causes chronic obstructive pulmonary disease
(COPD) exacerbations. We previously reported increased bronchial mucosa eosinophil and …
(COPD) exacerbations. We previously reported increased bronchial mucosa eosinophil and …
[HTML][HTML] Relationship between blood eosinophils and systemic corticosteroid therapy in COPD exacerbation
Y Gong, H Sun - International Journal of General Medicine, 2022 - ncbi.nlm.nih.gov
Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD
Exacerbation - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Exacerbation - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …